We analyse the investments made in the Dental Tech sector from a corporate finance point of view. In this case we will analyse Straumann's investment in Createch Medical.
Get in touch with our experts.
We analyse the investments made in the Dental Tech sector from a corporate finance point of view. In this case we will analyse Straumann's investment in Createch Medical.
Analysis of the Dental Tech sector
Experts agree that the future of dentistry is digital. From practice management to digital radiography and the most advanced and specialised cone beam technologies and CAD/CAM systems.
In the near future, doctors and dentists will increasingly tailor treatment to your personal genetics, making decisions that reflect what has been shown to be most effective for your particular genome and physiology.
On the investment side, this news has brought investors' attention. Venture capital funds have disbursed $ 146 million so far this year in dental companies. Last year, they spent $ 326 million on 38 deals, an incredible year for VCs.
The dental market in Spain consists of more than 800 companies and, according to figures provided by Fenin (Spanish Federation of Healthcare Technology Companies), generates a value of 713 million euros, a figure that is 8.7% more than the previous year.
CORPORATE FINANCE EXPERTS
Analysis of investment in Createch Medical
Straumann, a Swiss company specialising in implants, restoration and regenerative dentistry, has become the sole shareholder of the Spanish company Createch Medical, after acquiring the 70% of the company it did not already own for approximately CH 14M. The Swiss group also intends to increase its current workforce of around fifty highly qualified professionals in order to respond to the expected increase in activity.
In addition to improving equipment, increasing the workforce and strengthening R&D, Straumann plans to expand its international presence for Createch Medical. Europe is already a successful market, to which 70% of its exports are directed, and the challenge now lies in other destinations such as the United States or Japan.
Createch Medicalbased in Mendaro, Guipúzcoa, is dedicated to the manufacture of dental and maxillofacial prostheses using CAM/CAD technology.
Straumann is the world's leading dental company in implant, restorative and regenerative dentistry. Straumann researches, develops and manufactures dental implants, instruments, prosthetics and dental biomaterials for use in tooth replacement and restoration or to prevent tooth loss.
International companies in the Dental Tech sector
With regard to the international framework, the following leading companies in the Dental Tech sector should be highlighted:
Smartee Denti-Technology is a Chinese orthodontic company professional in integrating applications of 3D printing technology, three-dimensional computer-aided design technology, rapid digital prototyping for prosthetics and other dental solutions. Its $7.3M round at the end of 2017 is noteworthy.
Sun Dental Holdings of the United States is the leading dental technology and device manufacturing company. The company offers traditional manufacturing and a unified digital technology manufacturing platform that integrates 3D printing into the denture manufacturing process.
Nobel Biocare is a company focused on implant-based dental restorations, from single-tooth to fully edentulous indications. We offer dental implant systems, high-precision individualised prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials.
Other posts that may interest you
https://bakertillygda.com/analisis-de-inversion-en-telemedicina-toushka-capital-invierte-en-ever-health/
Telemedicine investment analysis. Atrys Health acquires Telrads.
Investment analysis in the hospital engineering sector. CIECA and DIAL Group
If you are looking for investors, want to buy or sell your company or finance your R&D&I project, contact our Corporate Finance experts.
If you are looking for investors, want to buy or sell your company or finance your R&D&I project, contact our Corporate Finance experts.